Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C42H64N2.2C16H18N2O4S |
Molecular Weight | 1265.751 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC3=CC=CC=C3)C(O)=O.[H][C@]45SC(C)(C)[C@@H](N4C(=O)[C@H]5NC(=O)CC6=CC=CC=C6)C(O)=O.[H][C@@]78CCC9=C(C=CC(=C9)C(C)C)[C@@]7(C)CCC[C@@]8(C)CNCCNC[C@]%10(C)CCC[C@]%11(C)C%12=C(CC[C@@]%10%11[H])C=C(C=C%12)C(C)C
InChI
InChIKey=BIPGVSDEAYGJOG-YQUITFMISA-N
InChI=1S/C42H64N2.2C16H18N2O4S/c1-29(2)31-11-15-35-33(25-31)13-17-37-39(5,19-9-21-41(35,37)7)27-43-23-24-44-28-40(6)20-10-22-42(8)36-16-12-32(30(3)4)26-34(36)14-18-38(40)42;2*1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h11-12,15-16,25-26,29-30,37-38,43-44H,9-10,13-14,17-24,27-28H2,1-8H3;2*3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t37-,38-,39-,40-,41+,42+;2*11-,12+,14-/m011/s1
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
145.5 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17371819/ |
30 mg/kg 2 times / day multiple, intravenous dose: 30 mg/kg route of administration: Intravenous experiment type: MULTIPLE co-administered: |
PENICILLIN G plasma | Homo sapiens population: UNHEALTHY age: NEWBORN sex: FEMALE / MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
23360.2 μg × min/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17371819/ |
30 mg/kg 2 times / day multiple, intravenous dose: 30 mg/kg route of administration: Intravenous experiment type: MULTIPLE co-administered: |
PENICILLIN G plasma | Homo sapiens population: UNHEALTHY age: NEWBORN sex: FEMALE / MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
3.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17371819/ |
30 mg/kg 2 times / day multiple, intravenous dose: 30 mg/kg route of administration: Intravenous experiment type: MULTIPLE co-administered: |
PENICILLIN G plasma | Homo sapiens population: UNHEALTHY age: NEWBORN sex: FEMALE / MALE food status: UNKNOWN |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
40% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17371819/ |
30 mg/kg 2 times / day multiple, intravenous dose: 30 mg/kg route of administration: Intravenous experiment type: MULTIPLE co-administered: |
PENICILLIN G plasma | Homo sapiens population: UNHEALTHY age: NEWBORN sex: FEMALE / MALE food status: UNKNOWN |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76964871
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | |||
|
DTXSID20187084
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | |||
|
667Y1107D3
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | |||
|
3344-16-9
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | |||
|
222-092-3
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | |||
|
m385
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB14790MIG
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY | |||
|
100000079754
Created by
admin on Fri Dec 15 14:57:50 GMT 2023 , Edited by admin on Fri Dec 15 14:57:50 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD